This MEDVi review starts with two numbers that refuse to agree. On Trustpilot, MEDVi holds about 4.4 out of 5 across roughly 14,000 reviews. At the Better Business Bureau, it holds an F — with 662 complaints filed and 100 left unanswered. Same company, same year. The pricing tells its own double story: $179 for your first month of compounded semaglutide, then $299 every month after — a 67% jump the ads do not lead with. We score MEDVi 7.6/10 (Good): real value and rare transparency on pharmacies, attached to an accountability problem the company has not fixed.

MEDVi in 60 Seconds

MEDVi is a cash-pay GLP-1 telehealth clinic headquartered in Newark, Delaware, launched in 2023 per U.S. News. It sells compounded semaglutide and compounded tirzepatide in two forms — weekly injections and daily dissolvable tablets — plus brand-name Wegovy, Zepbound, and Ozempic when available. The company claims more than 100,000 patients have used the platform, per its own January 2026 press release.

Let’s say the required thing plainly: compounded GLP-1s are not FDA-approved. MEDVi’s own site states they are not FDA-approved or evaluated for safety, efficacy, or quality. That is the trade behind a $299 price tag instead of a $1,999 one.

MEDVi Review Scorecard

Fact Detail
Our score 7.6/10 — Good
Launched 2023 (MEDVi, LLC — Newark, DE)
Semaglutide injection $179 first month, then $299/mo — flat at every dose
Semaglutide tablets $249 first month; refill price not published
Tirzepatide From $349 first month; refills $399–$499, per third-party pricing reports
Insurance Not accepted — cash-pay only (HSA/FSA OK)
Trustpilot ~4.4/5 across ~14,000 reviews
BBB F rating, not accredited; 662 complaints, 100 unanswered (July 2026)
Coverage 49 states, per U.S. News

The 7.6 lands where it does because the semaglutide pricing is flat, bundled, and 100% membership-fee-free — and because MEDVi does something rare in this market: it names the pharmacies that compound its drugs. It stays out of the 8s because an F from the BBB, driven by 100 ignored complaints, is exactly the kind of fine print this site exists to call out.

MEDVi Cost Breakdown (2026)

MEDVi’s official pricing page renders its numbers through scripts, so we verified every figure below through the company’s January 7, 2026 press release and third-party pricing reports. Here is the full sheet.

Medication First month Refills
Compounded semaglutide injection $179 $299/mo, flat at every dose
Compounded semaglutide tablets $249 Not published; third-party reviews cite up to $369
Compounded tirzepatide From $349 $399–$499 by dose, per third-party pricing reports
Brand-name Wegovy / Zepbound $99 membership + medication cost Same structure
Brand-name Ozempic $1,999/mo, per company press release

The compounded plans are advertised as all-inclusive: provider review, medication, free expedited shipping, and unlimited telehealth support in one bill, with no membership fee. Brand-name plans work differently — they bolt a $99 membership fee onto the drug cost. Before accepting a $1,999 Ozempic sticker from anyone, check our Ozempic cost without insurance guide for what the brand drug actually runs.

The $179-to-$299 Jump

The headline price lasts exactly one month. Refills jump 67%, from $179 to $299. Billed monthly, year one on semaglutide injections costs $179 + 11 × $299 = $3,468.

Now the wrinkle. One third-party review site reports that MEDVi bills on a 28-day cycle — about 13 charges per year, not 12. On that math, year one climbs to roughly $3,767. We could not confirm the cycle length on the official site, so read your checkout terms before you subscribe. A $299 “month” that is really four weeks costs you an extra refill every year.

Two more flags worth bolding. The flat-rate promise applies to the semaglutide injection plan — MEDVi does not publish tablet or tirzepatide refill prices at all, and third parties report tirzepatide refills of $399 to $499 depending on dose. And refunds are generally not available once medication has been dispensed for a cycle. Once the vial ships, that $299 is gone.

What Customers Complain About — and What They Praise

Start with the good, because there is a lot of it. MEDVi’s Trustpilot profile shows about 4.4 out of 5 across roughly 14,000 reviews — one of the largest review volumes of any platform we rank. A sample that big holding a 4.4 average means the core loop — approval, shipping, refill — works as promised for most buyers, most of the time.

Now the ugly. The Better Business Bureau rates MEDVi an F, its lowest grade. The file, opened March 17, 2025, logs 662 complaints, and the BBB specifically cites the company’s failure to respond to 100 of them. MEDVi is not BBB accredited.

The complaint themes repeat across both platforms. Loudest: unauthorized auto-renewal charges, often $399, landing after customers believed they had canceled. Close behind are double billing reports and plain difficulty cancelling — multiple contact attempts before the charges stop. Pair that with the no-refund-after-dispensing policy and a disputed charge becomes a lost one.

What This MEDVi Review Makes of the Split Record

How does one company hold a 4.4 and an F at the same time? Do the math. Against a claimed 100,000+ patient base, 662 complaints is a rate under 1%. The F is not really about the complaint rate — it is about the silence. BBB grades punish unanswered complaints hardest, and 100 ignored files is a choice, not an accident.

One caveat cuts MEDVi some slack: it is frequently confused with MEDvidi, an unrelated mental-health telehealth company, and some negative reviews are misdirected between the two. That muddies the water. It does not explain away 662 complaints sitting on MEDVi’s own BBB file.

How Ordering From MEDVi Works

The process is standard asynchronous telehealth, with a couple of MEDVi-specific details. Five steps.

Step 1: The evaluation. You complete a short online medical intake. Note the fine print MEDVi itself states: enrollment and payment do not guarantee a prescription.

Step 2: Provider review. Independent licensed clinicians via OpenLoop Health — not MEDVi employees — review your file, most within 24 hours per the company. No video visit is required in most states, though some states require a virtual face-to-face consultation, and a free doctor consult can be requested.

Step 3: Pharmacy fulfillment. This is MEDVi’s best trust signal. It names its compounding partners on the official site: Triad Rx (Daphne, AL), RedRock Pharmacy (St. George, UT), and Beaker Pharmacy & Compounding (McKinney, TX); the reviewer glp-1.com also names Belmar Pharma Solutions. Most rivals hide behind vague “FDA-registered facility” language. One gap remains: MEDVi does not state the pharmacies’ 503A/503B status.

Step 4: Delivery. Shipping is free and expedited, and treatment typically starts in about a week.

Step 5: Ongoing support. Unlimited telehealth support is bundled into the monthly price, with no per-message or per-visit fees on compounded plans.

Set expectations with trial data, not marketing. In the STEP 1 trial, semaglutide 2.4 mg averaged about 14.9% body-weight loss over 68 weeks. In SURMOUNT-1, tirzepatide reached up to about 20.9% over 72 weeks at the highest dose. Both results come from the FDA-approved versions of these drugs. The FDA has publicly flagged concerns with unapproved compounded GLP-1s — including dosing errors and quality uncertainty — and compounded copies are what MEDVi primarily ships.

MEDVi vs bmiMD

Our top alternative is bmiMD (8.2, Very Good) — operating since late 2022, with prices verified on live product pages instead of press releases.

MEDVi bmiMD
Our score 7.6 (Good) 8.2 (Very Good)
Semaglutide $179 first month, then $299/mo $99/mo (12-month plan); $129 monthly
Tirzepatide From $349; refills $399–$499, third-party reported From $139/mo (12-month plan)
Trustpilot ~4.4/5 (~14,000 reviews) Roughly 4 stars
BBB F, 662 complaints, 100 unanswered C+
Transparency Pharmacies named on site Third-party potency and sterility testing published

On price, it is a rout. bmiMD’s $99/mo twelve-month semaglutide rate is about a third of MEDVi’s $299 refill price — roughly $2,280 saved over a year against MEDVi’s $3,468. Even bmiMD’s month-to-month $129 undercuts MEDVi’s one-time $179 promo.

MEDVi punches back on format and disclosure. It offers daily dissolvable tablets for the needle-averse — genuinely rare — and it tells you exactly which pharmacies compound your medication. Its 14,000-review Trustpilot base also dwarfs most competitors’ samples. But bmiMD pairs lower prices with a cleaner BBB record and no-charge-until-approved billing, and that combination wins. Read our full bmiMD review, then see how both stack against the entire field in our best online weight loss clinics ranking.

Final Verdict: Who Should Actually Buy

Buy MEDVi if you want a flat $299 refill that never rises with your dose, a tablet option instead of injections, and the reassurance of named pharmacies. The bundle is real: consult, medication, expedited shipping, and support in one bill, HSA/FSA accepted, approvals typically inside 24 hours. At $3,468 for year one, MEDVi sits mid-market — far below the $1,999-a-month brand tier, well above the budget leaders.

Skip MEDVi if a pile of ignored complaints bothers you — and it should. An F from the BBB with 100 unanswered complaints is a louder warning than any single angry review. Skip it too if you want refund protection, because there is none once medication ships, or if you want the lowest price, because bmiMD charges $99/mo against MEDVi’s $299.

Against the rest of our rankings, 7.6 puts MEDVi solidly mid-table. It clearly outranks OMZO (6.9, Fair), where the marketing promises outrun the refund terms, but it cannot touch Ro (8.8, Very Good) on trust signals and accountability.

The bottom line of this MEDVi review: a Good platform with honest flat pricing, rare pharmacy transparency, and a customer-service record its own BBB file contradicts. Use it with eyes open. Calendar every renewal date, screenshot your cancellation, and never assume an auto-renewal stopped because you asked once.